Catalina Holdings has committed £5 million to the British Lung Foundation (BLF) to accelerate research into mesothelioma, an aggressive form of lung cancer related to asbestos exposure.
Catalina will give £1 million to the BLF each year for the next five years, with funding directed towards research aimed at achieving improved early diagnosis and trials of high potential drugs.
Mesothelioma kills around 2,500 people every year in the UK alone, the illness often developing over a period of decades. Only around 5–10 percent of people diagnosed with mesothelioma will survive for five years or more.
Chris Fagan, CEO at Catalina, said: “As one of the leading players in the UK employer liability run-off industry, Catalina’s support for their research stands to make a significant difference.”
Ian Jarrold, head of research at the BLF, thanked Catalina for the donation. “This funding will support crucial research into this horrible disease that could help thousands of people every year,” he added.
Catalina Holdings, British Lung Foundation, Mesothelioma, Chris Fagan, Ian Jarrold